 |
|
|
| |
Once daily alisporivir (DEB025) plus Peg-IFN-alfa-2A/ ribavirin results in superior sustained virologic response (SVR24) in chronic hepatitis C genotype 1 treatment-naïve patients - The ESSENTIAL study
|
| |
| |
Reported by Jules Levin
EASL March 31 2011 Berlin Germany
R Flisiak1, JM Pawlotsky2, R Crabbe3, PI Calistru4,
W Kryczka5, D Haussinger6, G Mazella7, M Romero8,
D Purcea3, G Vuagniaux3, W Bao9, C Avila9 and S Zeuzem10
1Medical University of Bialystok, Bialystok, Poland; 2Hopital Henri Mondor, Creteil, France; 3Debiopharm, Lausanne, Switzerland; 4Centrul de Diagnostic si Tratament Dr. Viktor Babes, Bucharest, Romania; 5Provincial Hospital, Kielce, Poland; 6Universitatsklinikum, Düsseldorf, Germany; 7University of Bologna, Bologna, Italy; 8Hospital Universitario Nuestra Señora de Valme, Sevilla, Spain; 9Novartis Pharma AG, Basel, Switzerland;
10J.W. Goethe University Hospital, Frankfurt, Germany
|
| |
|
|
|
|
|
